Pet Biomarker Expansion VDI Laboratory has developed validated biomarkers for common canine and feline conditions such as lymphoma, hemangiosarcoma, and sepsis, presenting opportunities to collaborate with veterinary clinics and diagnostics firms looking to expand their testing portfolios.

Innovative Diagnostic Solutions VDI's focus on innovative biomarkers and proprietary testing services, including those through its Glycominds CLIA-certified lab, can appeal to veterinary hospitals and specialty clinics seeking advanced diagnostic tools.

Recent Product Success The successful sale of NT-proBNP to IDEXX underlines VDI's potential as a supplier of novel biomarkers, creating potential sales channels with large veterinary diagnostic companies aiming to enhance their product lineup.

Market Differentiation With a niche focus on companion animal biomarkers and ongoing research, VDI offers unique market differentiation opportunities for partners prioritizing innovation and personalized veterinary care.

Technology Infrastructure Utilizing contemporary web infrastructure and lab certification, VDI demonstrates a capacity for scalable, reliable diagnostic service delivery, which can be leveraged in sales pitches emphasizing quality and technological robustness.